Masimo | MASI - Umsatzkosten

Aktienkurs
178.42
Täglich Wechseln
-0.04 -0.02%
Monatlich
0.31%
Jährlich
9.03%
Q2 Prognose
174.81




Umsatzkosten Veränderung Datum
Abbott USD 5.3B 380M 2026-03
Accuray USD 116.17M 14.63M 2024-12
Align Technology USD 303.5M 60.47M 2026-03
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.83B 8M 2026-03
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 362.6M 19.6M 2026-03
General Electric Aerospace USD 8.15B 764M 2026-03
Globus Medical USD 290.47M 8.09M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Orthofix International USD 66.63M 6.4M 2025-12
Owens Minor USD 436.92M 32.62M 2025-12
ResMed USD 555.85M 29.13M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03